Individual Study / UCORBIO

Utrecht Coronary Biobank

Utrecht Coronary Biobank

Initiatives -
UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter. At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed.
Start Year
2011
End Year
2014
Funding
UMC Utrecht
Visit UCORBIO

Members

Download
Investigators Contacts
  • MD, Dr Crystel Gijsberts
    University Medical Center Utrecht

Design

Study design
Patients' cohort
Follow Up
At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
2,589
Number of participants with biosamples
Supplementary Information
Patients undergoing coronary angiography with or without coronary intervention in the University Medical Center in Utrecht, the Netherlands.

Access

Availability of data and biosamples

Data
Biosamples
Other